Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
What works against self-stigma? First systematic review aims to find out

A systematic review of whether different interventions helped to overcome self-stigma in people in African and Asian countries who are living with or at risk of HIV

Published
24 May 2019
By
Gus Cairns
Early antiretroviral treatment may preserve key immune responses to HIV

Investigators from the Ragon Institute of MGH, MIT and Harvard have found that instituting combination antiretroviral treatment at the earliest stages of HIV infection may allow the generation of functional CD8 'killer' T cells and preservation of the CD4 helper T cells that are the virus's primary target.

Published
23 May 2019
From
Eurekalert Inf Dis
Immediate HIV treatment initiation has improved but not yet universal in NYC, study finds

A new study published in the Journal of Infectious Diseases found that immediate treatment initiation for HIV infection has improved since local and federal guidelines began to recommend universal treatment for all persons diagnosed with HIV, regardless of their disease stage.

Published
07 May 2019
From
News-Medical.net
Most UK clinic staff now tell people about U=U, but not always in the same way

Two presentations at this month’s British HIV Association (BHIVA) conference in Bournemouth show that most specialist healthcare workers are now informing people with HIV that if their

Published
29 April 2019
By
Gus Cairns
US regulators approve new two-drug combination pill for HIV

The US Food and Drug Administration (FDA) this week approved Dovato, a new single-tablet antiretroviral regimen containing the HIV integrase inhibitor dolutegravir (sold separately as Tivicay) and

Published
11 April 2019
By
Liz Highleyman
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
The length of time Americans with HIV remain infectious is falling, but slowly

In 2016, more than half of people with HIV in the United States took more than three years to be diagnosed, and more than five months after

Published
07 March 2019
By
Roger Pebody
Integrase inhibitors give greater chance of viral suppression at delivery in pregnant women

Integrase inhibitor-based treatment with either raltegravir (Isentress) or dolutegravir (Tivicay, also in Triumeq) reduces viral load more rapidly than efavirenz if started in pregnancy, findings from

Published
06 March 2019
By
Keith Alcorn
Atripla or efavirenz plus Truvada failed one in 16 people in first year

Although analyses of the failure rate of ART have been conducted before, a new analysis is the first to compute these rates for a single-drug regimen

Published
21 January 2019
By
Gus Cairns
Back to the future with CD4 testing: Improving HIV care in low- and middle-income countries

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.

Published
16 January 2019
From
Science Daily
← First12345...82Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.